PROCEPT BioRobotics (PRCT) EBT (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of EBT data on file, last reported at -$31.7 million in Q1 2026.

• EBT for Q1 2026 came in at -$31.7 million, down 27.83% year-over-year; the trailing twelve-month figure through Mar 2026 was -$102.3 million (down 13.86% YoY), and the FY2025 annual result was -$95.4 million, down 4.76% from the prior year.
• EBT declined to -$31.7 million in Q1 2026 per PRCT's latest filing, from -$29.7 million in the prior quarter.
• Over five years, EBT peaked at -$17.2 million in Q1 2022 and troughed at -$31.7 million in Q1 2026.
• A 5-year average of -$24.0 million and a median of -$24.8 million in 2025 frame the typical range for EBT.
• The sharpest annual moves came in 2023 and 2024: EBT slumped 65.75% in 2023, then jumped 32.58% in 2024.
• A 5-year view of EBT shows it stood at -$24.9 million in 2022, then declined by 10.07% to -$27.4 million in 2023, then jumped by 32.58% to -$18.5 million in 2024, then slumped by 60.4% to -$29.7 million in 2025, then decreased by 6.83% to -$31.7 million in 2026.
• Business Quant data shows PRCT's EBT at -$31.7 million in Q1 2026, -$29.7 million in Q4 2025, and -$21.4 million in Q3 2025.